What is Risperdal®?

Written by Michael Monheit, Esquire, Monheit Law, PC


What is Risperdal?

How is Risperdal® different than other drugs? How long does it take for Risperdal® to start working? How long do I need to take Risperdal®? Will Risperdal® improve how I feel? What arerepparttar typical side effects of Risperdal®? What other side effects exist? Studies onrepparttar 114644 safety of Risperdal®

--------------------------------------------------------------------------------

What is Risperdal? RISPERDAL®, generically known as risperidone, is an FDA approved medication for treatment of bipolar I disorder and is also approved or to treat acute to manic or mixed episodes associated with bipolar I disorder. It is approved for use as therapy alone or in combination with drugs called mood stabilizers, such as lithium or valproate. Risperdal is also approved for bipolar mania.

The drug was released in 1994 and is prescribed worldwide. It is one of a family of “atypical antipsychotic medications” used to treat schizophrenia and psychotic disorders. Risperdal® improves schizophrenia's positive symptoms (e.g., visual and auditory hallucinations, delusions, and thought disturbances) and may also help treatrepparttar 114645 illness’ negative symptoms (e.g., social withdrawal, apathy, lack of motivation, and inability to experience pleasure).

--------------------------------------------------------------------------------

How does Risperdal® work? In order to treat chemical imbalances associated with bipolar mania, dopamine and serotonin levels are controlled usingrepparttar 114646 drug. Whilerepparttar 114647 specific details of how Risperdal® does this are not known, testing shows that Risperdal® adjustsrepparttar 114648 balance of dopamine and serotonin thereby reducingrepparttar 114649 bipolar mania. It is important to note thatrepparttar 114650 Risperdal® does not cure, but only helps to controlrepparttar 114651 mania.

Risperdal®, like some other atypical antipsychotics, is designed as a serotonin/dopamine antagonist. Apparently, Risperdal blocksrepparttar 114652 serotonin and dopamine, two neurotransmitter chemicals inrepparttar 114653 brains.

--------------------------------------------------------------------------------

How is Risperdal® different than other drugs? Conventional antipsychotics seem to primarily affect only dopamine. Risperdal® affects both. Antipsychotics such as Haldol, Stelazine, and Prolixin have treated symptoms in many patients. However, these drugs do not satisfactorily affectrepparttar 114654 negative (depressive) symptoms, Risperdal® has been shown to be as effective asrepparttar 114655 conventional medications in treating positive symptoms.

--------------------------------------------------------------------------------

How long does it take for Risperdal® to start working? Improvement of symptoms may be noticed in some patients relatively quickly. It can take anywhere from a few days to a few weeks for a patient taking Risperdal® to see benefits. Therefore, usually doctors inform their patients to not expect immediate results, but to giverepparttar 114656 drug time to take full effect. Some adjustments may be necessary to reachrepparttar 114657 optimal dose for each patient.

Forbe's writes, "Forget Bextra"

Written by Michael Monheit, Esquire, Monheit Law, PC


On November 10, 2004, according to Forbes Magazine, "Pfizer was blindsided as The New York Times reported information about a reanalysis of old data that sayrepparttar drug giant's Bextra, which is similar to Merck's Vioxx, increasedrepparttar 114643 risk of heart attacks and strokes." However, one has to ask, how much of a blind side could it possibly be, when Pfizer receives that asdverse reports from doctors whose patients are having these side effects, such as heart attacks and strokes? Only time will tell how much Pfizer knew before. Looking back a month, Pfizer decided to update its warning. So it appears clear that they saw this coming.

Whilerepparttar 114644 link to strokes and heart attacks in all patients may not be clear at this point. It seems that it is only a matter of time. Forbes receommends thatrepparttar 114645 "executives should start thinking about Bextra as a lost cause, partly because it will make it easier forrepparttar 114646 company to defend Celebrex, which is Bextra's chemical cousin and one of Pfizer's best-selling drugs."

Pfizer is sure to be pulled intot he mix asrepparttar 114647 FDA convenes a panel to look at all Cox-2 drugs. This may actually be a boon for Pfizer, who can narrow its focus on how Celebrex may be safer, as it does not take Cox-1 and Cox-2 as far out of balance with each other. It may be better, albeit having a greater risk of ulcers.

The information was release by Dr. Garret FitzGerald, a pharmacologist atrepparttar 114648 University of Pennsylvania, in a lecture he was giving here atrepparttar 114649 American Heart Association's annual meeting. However, it is not a detailed study, and only a retrospective looking back at data. Pfizer has already admitted that open heart surgery data showed an increased risk of heart attack and stroke in those patients. Pfizer disclosed information about those studies in increased warning letters approved byrepparttar 114650 FDA and sent to doctors on Oct. 15.

Cont'd on page 2 ==>
 
ImproveHomeLife.com © 2005
Terms of Use